Acetylcholinesterases (AChEs) are the enzymes responsible for the degradation of ACh and are potential targets for the treatment of AD since the dysfunction of cholinergic neurons is considered one of the major causes of cognitive impairment in AD patients. Here, ACHE is linked to Alzheimer disease.